Company Overview and News
European Lithium (ASX:EUR) has restarted drilling as expected after pausing for the Christmas period at the 100% owned Wolfsberg Lithium Project located in Austria.
European Lithium (ASX:EUR) has executed a binding term sheet for the sale of its gold project in Western Australia in exchange for cash and shares valued at $1 million.
European Lithium (ASX:EUR) is continuing the aggressive development of the Wolfsberg Lithium Project located in Austria on schedule with the planned timetable.
European Lithium Ltd (ASX:EUR) has declared a total JORC resource of 6.3 million tonnes at 1.17% lithium oxide at its 100% owned Wolfsberg lithium project in Austria.
European Lithium Ltd (ASX:EUR) has verified original data for use in an imminent JORC resource upgrade at the 100% owned Wolfsberg lithium project in Austria.
European Lithium Ltd (ASX:EUR, FRA:PF8) has delivered high-grade lithium from channel sampling of underground pegmatite veins at its wholly-owned Wolfsberg Project in Austria.
European Lithium Ltd (ASX:EUR) has commenced a metallurgical test work program to optimise process design for its Wolfsberg lithium project located in Austria. Historical test work completed at project from the 1980s concluded that a 6% lithium oxide spodumene concentrate could be obtained. Since the original test work there have been a number of technological developments that could be applicable to the Wolfsberg deposit.
European Lithium Ltd (ASX:EUR) has completed its drilling program at the Wolfsberg Lithium Project in Austria which aims to support an updated JORC 2012 resource. The objective of the drilling program was to verify 17,000 metres of historical surface and underground drilling. The company expects the analysis of the drilling samples to be completed by mid-October. This will enable the verification program report to be completed which will progress towards an upgraded JORC Code 2012 compliant resource by the end of October or early November 2016.
Paynes Find Gold Ltd (ASX:PNE) has completed its due diligence ahead of its proposed acquisition of a JORC compliant inferred resource of 3.7 million tonnes grading 1.5% lithium. Paynes is now seeking shareholder approval to acquire European Lithium Limited, the 100% owner of the Wolfsberg Lithium Project in Austria. The project is located 40 kilometres from the Samsung battery plant in Gratz, Austria.
Cape Lambert Resources Ltd (ASX:CFE) has sold its 20% interest in Central African Resources Ltd (CAR) for circa A$550,000. The company held 20% of CAR which has iron ore tenements in Gabon. Tony Sage, executive chairman, commented: “This transaction has enabled the company to increase it’s cash reserves as well as reducing our exposure to iron ore given the current state of that market.”
Paynes Find Gold Ltd (ASX:PNE) is seeking to become a lithium miner through the reverse takeover and backdoor listing of European Lithium Limited, the sole owner of the well advanced Wolfsberg Lithium Project in Austria. Tony Sage will become a director of the company, as Cape Lambert Resources Ltd (ASX:CFE) owns 26.2% of the pre-raising capital in Euro Lithium. The current vendors have already spent €11.
2h - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...